Brieflands
Journal finderSearch
·
Sign in

Iranian Journal of Pharmaceutical Research

e-ISSN 1726-6890
p-ISSN 1735-0328
Home
Archives
    Current IssueAll IssuesIn PressAccepted Manuscripts
Search
Instructions
About Journal
    Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Iranian Journal of Pharmaceutical Research
  6. /
  7. Articles
  8. /
  9. The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI)
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

5 results·Updated September 19, 2026
← Back to article
1

The effect of calcitriol and cholecalciferol on inflammatory markers in periprocedural myocardial injury A randomized controlled trial

Medicine United States

11 April 2025

Mahmoudi L.

Open Access

2

The Effect of Rosuvastatin and Calcitriol on Preventing Voice Change After Thyroidectomy: A Randomized Controlled Trial

Journal of Voice

2025

Ghasemian M.

3

Natural sea salt in diet ameliorates better protection compared to table salt in the doxorubicin-induced cardiac remodeling

Journal of Taibah University for Science

2022

Anwar F.

Open Access

4

Effect of evidence-based clinical nursing pathway on emergency thrombolytic therapy in patients with acute cerebral infarction

Chinese Journal of General Practice

June 2021

Wang F.Q.

5

In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention

Journal of Diabetes Research

2021

Liu F.

Open Access

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.